How much revenue does Hanshang Group make?

Hanshang Group reported 1.03 billion CNY in revenue for fiscal year 2025, down 12.2% from 1.18 billion CNY in fiscal year 2024. In Q1 2026 revenue was 227.88 million CNY.

What is Hanshang Group's largest business segment?

Pharmaceuticals and Medical Devices Division, with 873.20 million CNY or 74% of segment revenue in fiscal year 2024. Next: Commercial Operations Division (16%) and Exhibition Business Division (6%).

What companies are similar to Hanshang Group?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ), Honz Pharmaceutical Co., Ltd. (300086.SZ), ShanXi C&Y Pharmaceutical Group Co.,LTD. (300254.SZ), Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (301130.SZ).

Hanshang Group Co., Ltd. (600774.SS) Stock

About Hanshang Group Co., Ltd.

Hanshang Group Co., Ltd. primarily engages in the retail business. It is also involved in medicine, medical equipment, assisted reproduction, healthy drinks, and exhibition operations. The company was incorporated in 1990 and is based in Wuhan, China.

At a glance

Hanshang Group reported revenue of 1.03 billion CNY for fiscal year 2025, down 12.2% from fiscal year 2024, and net income of -174.83 million CNY. In Q1 2026 (the quarter ended March 31, 2026) revenue was 227.88 million CNY, down 11.5% from a year before. Its largest business segment, Pharmaceuticals and Medical Devices Division, brought in 74% of segment revenue in fiscal year 2024.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.